A new study reports that young adults experienced a 70% reduction in depression symptoms after following a ketogenic diet, ...

The study involved participants from a trial published in 2021 that found psilocybin—the primary psychedelic substance ...

In a new analysis of people who took part in a 2020 psilocybin clinical trial, 67 percent were still in full remission from ...

The FDA clearance expands the acceptable protocols for BrainsWay's deep transcranial magnetic stimulation, a non-invasive treatment used to treat patients with major depressive disorder, including ...

BrainsWay Ltd. (NASDAQ:BWAY) saw its stock rise 6.3% on Tuesday after the U.S. Food and Drug Administration (FDA) approved an ...

BrainsWay (Nasdaq:BWAY) today announced the FDA granted expanded clearance for its Deep Transcranial Magnetic Stimulation system.

A ketogenic diet (KD) is a feasible adjunctive therapy and is associated with improvements in depression symptoms among young adults with major depressive disorder (MDD), according to a study ...

A study found that a ketogenic diet reduced depression symptoms by 70% in students, improved well-being, and supported brain ...

New research reveals patients who treated their depression with magic mushrooms were still free of symptoms five years later.

A more precise and personalized form of electric brain stimulation may be a more effective and faster treatment for people ...

When added to antidepressant therapy, lumateperone is linked to significantly greater improvements in MDD symptoms and ...

Founded by two neuroscientists, NeuroKaire says its novel, AI-assisted tech uses stem cells to create a brain proxy against ...